Low plasma BDNF is associated with suicidal behavior in major depression

Yong Ku Kim, Heung Pyo Lee, Sung Doo Won, Eun Young Park, Hwa Young Lee, Bun Hee Lee, Sung Woo Lee, Dokyung Yoon, Changsu Han, Dai Jin Kim, So Hyun Choi

Research output: Contribution to journalArticle

180 Citations (Scopus)

Abstract

Brain-derived neurotrophic factor (BDNF), the most abundant neurotrophin in the brain, has a known association with the pathophysiology of anxiety and depression. However, the role of BDNF in suicide has not been well investigated to date. This study examined plasma BDNF levels in 32 major depressive disorder (MDD) patients who had recently attempted suicide, 32 non-suicidal MDD patients, and 30 normal controls. The lethality of the suicide attempt was measured using the Risk-Rescue Rating (RRR) and Lethality Suicide Attempt Rating Scale (LSARS). The severity of depression was measured with the Hamilton Depression Rating Scale (HDRS). Plasma BDNF levels were measured by enzyme linked immunosorbent assay. BDNF levels were significantly lower in suicidal MDD patients (430.5 ± 397.0 pg/ml) than non-suicidal MDD patients (875.80 ± 663.02 pg/ml) or normal controls (889.4 ± 611.3 pg/ml) (F = 6.682, p = 0.002). The most suitable cut-off point of BDNF level between suicidal depression and non-suicidal depression groups was 444.58 pg/ml. At this cut-off point, the sensitivity = 68.7%, specificity = 78.1%, positive predictive value = 75.9%, and negative predictive value = 71.4%. However, there was no significant difference in BDNF levels between the depressive control and normal control groups (p = 0.996). LSARS and RRR did not reveal any significant correlations with BDNF levels in suicidal patients. In addition, BDNF levels were not different between fatal and non-fatal suicide attempts. These results suggest that reduction of plasma BDNF level is related to suicidal behavior in major depression and that BDNF level may be a biological marker of suicidal depression.

Original languageEnglish
Pages (from-to)78-85
Number of pages8
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume31
Issue number1
DOIs
Publication statusPublished - 2007 Jan 30

Fingerprint

Brain-Derived Neurotrophic Factor
Depression
Suicide
Major Depressive Disorder
Attempted Suicide
Nerve Growth Factors
Anxiety
Biomarkers
Enzyme-Linked Immunosorbent Assay
Sensitivity and Specificity
Control Groups

Keywords

  • BDNF
  • Depression
  • Lethality of Suicide Attempt Rating Scale
  • Suicide
  • Weisman and Worden's Risk-Rescue Rating

ASJC Scopus subject areas

  • Pharmacology
  • Biological Psychiatry

Cite this

Low plasma BDNF is associated with suicidal behavior in major depression. / Kim, Yong Ku; Lee, Heung Pyo; Won, Sung Doo; Park, Eun Young; Lee, Hwa Young; Lee, Bun Hee; Lee, Sung Woo; Yoon, Dokyung; Han, Changsu; Kim, Dai Jin; Choi, So Hyun.

In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 31, No. 1, 30.01.2007, p. 78-85.

Research output: Contribution to journalArticle

Kim, Yong Ku ; Lee, Heung Pyo ; Won, Sung Doo ; Park, Eun Young ; Lee, Hwa Young ; Lee, Bun Hee ; Lee, Sung Woo ; Yoon, Dokyung ; Han, Changsu ; Kim, Dai Jin ; Choi, So Hyun. / Low plasma BDNF is associated with suicidal behavior in major depression. In: Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2007 ; Vol. 31, No. 1. pp. 78-85.
@article{021a4cd0fb8d4f7695ae80d77b0cb3c7,
title = "Low plasma BDNF is associated with suicidal behavior in major depression",
abstract = "Brain-derived neurotrophic factor (BDNF), the most abundant neurotrophin in the brain, has a known association with the pathophysiology of anxiety and depression. However, the role of BDNF in suicide has not been well investigated to date. This study examined plasma BDNF levels in 32 major depressive disorder (MDD) patients who had recently attempted suicide, 32 non-suicidal MDD patients, and 30 normal controls. The lethality of the suicide attempt was measured using the Risk-Rescue Rating (RRR) and Lethality Suicide Attempt Rating Scale (LSARS). The severity of depression was measured with the Hamilton Depression Rating Scale (HDRS). Plasma BDNF levels were measured by enzyme linked immunosorbent assay. BDNF levels were significantly lower in suicidal MDD patients (430.5 ± 397.0 pg/ml) than non-suicidal MDD patients (875.80 ± 663.02 pg/ml) or normal controls (889.4 ± 611.3 pg/ml) (F = 6.682, p = 0.002). The most suitable cut-off point of BDNF level between suicidal depression and non-suicidal depression groups was 444.58 pg/ml. At this cut-off point, the sensitivity = 68.7{\%}, specificity = 78.1{\%}, positive predictive value = 75.9{\%}, and negative predictive value = 71.4{\%}. However, there was no significant difference in BDNF levels between the depressive control and normal control groups (p = 0.996). LSARS and RRR did not reveal any significant correlations with BDNF levels in suicidal patients. In addition, BDNF levels were not different between fatal and non-fatal suicide attempts. These results suggest that reduction of plasma BDNF level is related to suicidal behavior in major depression and that BDNF level may be a biological marker of suicidal depression.",
keywords = "BDNF, Depression, Lethality of Suicide Attempt Rating Scale, Suicide, Weisman and Worden's Risk-Rescue Rating",
author = "Kim, {Yong Ku} and Lee, {Heung Pyo} and Won, {Sung Doo} and Park, {Eun Young} and Lee, {Hwa Young} and Lee, {Bun Hee} and Lee, {Sung Woo} and Dokyung Yoon and Changsu Han and Kim, {Dai Jin} and Choi, {So Hyun}",
year = "2007",
month = "1",
day = "30",
doi = "10.1016/j.pnpbp.2006.06.024",
language = "English",
volume = "31",
pages = "78--85",
journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",
issn = "0278-5846",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Low plasma BDNF is associated with suicidal behavior in major depression

AU - Kim, Yong Ku

AU - Lee, Heung Pyo

AU - Won, Sung Doo

AU - Park, Eun Young

AU - Lee, Hwa Young

AU - Lee, Bun Hee

AU - Lee, Sung Woo

AU - Yoon, Dokyung

AU - Han, Changsu

AU - Kim, Dai Jin

AU - Choi, So Hyun

PY - 2007/1/30

Y1 - 2007/1/30

N2 - Brain-derived neurotrophic factor (BDNF), the most abundant neurotrophin in the brain, has a known association with the pathophysiology of anxiety and depression. However, the role of BDNF in suicide has not been well investigated to date. This study examined plasma BDNF levels in 32 major depressive disorder (MDD) patients who had recently attempted suicide, 32 non-suicidal MDD patients, and 30 normal controls. The lethality of the suicide attempt was measured using the Risk-Rescue Rating (RRR) and Lethality Suicide Attempt Rating Scale (LSARS). The severity of depression was measured with the Hamilton Depression Rating Scale (HDRS). Plasma BDNF levels were measured by enzyme linked immunosorbent assay. BDNF levels were significantly lower in suicidal MDD patients (430.5 ± 397.0 pg/ml) than non-suicidal MDD patients (875.80 ± 663.02 pg/ml) or normal controls (889.4 ± 611.3 pg/ml) (F = 6.682, p = 0.002). The most suitable cut-off point of BDNF level between suicidal depression and non-suicidal depression groups was 444.58 pg/ml. At this cut-off point, the sensitivity = 68.7%, specificity = 78.1%, positive predictive value = 75.9%, and negative predictive value = 71.4%. However, there was no significant difference in BDNF levels between the depressive control and normal control groups (p = 0.996). LSARS and RRR did not reveal any significant correlations with BDNF levels in suicidal patients. In addition, BDNF levels were not different between fatal and non-fatal suicide attempts. These results suggest that reduction of plasma BDNF level is related to suicidal behavior in major depression and that BDNF level may be a biological marker of suicidal depression.

AB - Brain-derived neurotrophic factor (BDNF), the most abundant neurotrophin in the brain, has a known association with the pathophysiology of anxiety and depression. However, the role of BDNF in suicide has not been well investigated to date. This study examined plasma BDNF levels in 32 major depressive disorder (MDD) patients who had recently attempted suicide, 32 non-suicidal MDD patients, and 30 normal controls. The lethality of the suicide attempt was measured using the Risk-Rescue Rating (RRR) and Lethality Suicide Attempt Rating Scale (LSARS). The severity of depression was measured with the Hamilton Depression Rating Scale (HDRS). Plasma BDNF levels were measured by enzyme linked immunosorbent assay. BDNF levels were significantly lower in suicidal MDD patients (430.5 ± 397.0 pg/ml) than non-suicidal MDD patients (875.80 ± 663.02 pg/ml) or normal controls (889.4 ± 611.3 pg/ml) (F = 6.682, p = 0.002). The most suitable cut-off point of BDNF level between suicidal depression and non-suicidal depression groups was 444.58 pg/ml. At this cut-off point, the sensitivity = 68.7%, specificity = 78.1%, positive predictive value = 75.9%, and negative predictive value = 71.4%. However, there was no significant difference in BDNF levels between the depressive control and normal control groups (p = 0.996). LSARS and RRR did not reveal any significant correlations with BDNF levels in suicidal patients. In addition, BDNF levels were not different between fatal and non-fatal suicide attempts. These results suggest that reduction of plasma BDNF level is related to suicidal behavior in major depression and that BDNF level may be a biological marker of suicidal depression.

KW - BDNF

KW - Depression

KW - Lethality of Suicide Attempt Rating Scale

KW - Suicide

KW - Weisman and Worden's Risk-Rescue Rating

UR - http://www.scopus.com/inward/record.url?scp=33845635596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845635596&partnerID=8YFLogxK

U2 - 10.1016/j.pnpbp.2006.06.024

DO - 10.1016/j.pnpbp.2006.06.024

M3 - Article

C2 - 16904252

AN - SCOPUS:33845635596

VL - 31

SP - 78

EP - 85

JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry

SN - 0278-5846

IS - 1

ER -